FDA Inspection
Bioiberica, SAUBioiberica, SAU – FDA Inspection, Feb 4, 2022
Record Details
This FDA Inspection record concerns Bioiberica, SAU, with an inspection on February 4, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bioiberica, SAU
- Inspection Date
- February 4, 2022
- Product Type
- Drugs
View Company Profile
ID · 85b45235-a9fe-4749-a6ee-e13146b12c0c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1162922
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Bioiberica, SAU
7| Date | Classification | Office | Project area |
|---|---|---|---|
| September 20, 2024 | Not classified | Office of Inspections and Investigations | |
| December 17, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 21, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 23, 2017 | Not classified | Office of Inspections and Investigations | |
| May 28, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bioiberica, SAU
- FDA Inspection 1253863 - 2024-09-20
- FDA Inspection 1127299 - 2019-12-17
- FDA Inspection 1068320 - 2018-09-21
- FDA Inspection 1018467 - 2017-03-23
- FDA Inspection 932850 - 2015-05-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.